FindTrial
Sign In

A medical records based analysis for antiviral therapy effect on novel coronavirus pneumonia COVID-19 patients

A medical records based analysis for antiviral therapy effect on novel coronavirus pneumonia COVID-19 patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030391
Enrollment
Unknown
Registered
2020-03-01
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:NA

Sponsors

Lishui Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Confirmed cases of novel coronavirus pneumonia

Exclusion criteria

Exclusion criteria: 1. Pneumonia caused by other pathogens; 2. Not receiving antiviral treatment.

Design outcomes

Primary

MeasureTime frame
cure rate;virus negative rate;time of virus negative;—

Secondary

MeasureTime frame
disappearance time of main symptoms;disappearance rate of single symptom;improvement rate and time of lung CT at discharge;time from aggravation to ICU;—

Countries

China

Contacts

Public ContactChuxiao Shao

Lishui Central Hospital

scx1818@126.com+86 0578 2285102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026